April 2019 FDA Recall Drug by Pacifico National, Inc. Dba Amex Pharmacy
D-1271-2019 - Defective Delivery System

This Class II drug recall was voluntarily initiated by Pacifico National, Inc. Dba Amex Pharmacy on April 19, 2019 for the product Drug. The FDA reported the reason for recall as defective delivery system. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1271-2019

Reason for Recall
Defective Delivery System: difficult to express
Initiated
04-19-2019
Reported
05-08-2019
Quantity
249 syringes

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Pacifico National, Inc. dba AmEx Pharmacy
Nationwide in the US
BEVACIZUMAB 1.25 mg/0.05 mL 31G MJ syringe Intravitreal Injection. This biologic product was repackaged by AmEx Pharmacy 1515 Elizabeth St. Suite J Melbourne, FL 32901 Lot:190212AB BUD:5/13/2019, Repackaged on 2/12/2019

Batch or Lot Expiration Information

Lot# Lot: 190212AB BUD: 5/13/2019